Clinical Trial Update: : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the pharmacokinetics of enoxaparin following coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Thromboprophylaxis
• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Tampere University Hospital | Conditions: Venous Thromboembolism, Pulmonary Embolism | Phase 4 | Status: COMPLETED